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1. Introduction 
A biomaterial is defined as a material, either man-made or natural, intended to interact with 
biological systems. It does not have a chemical effect in the organism, nor thus it need to be 
metabolised to be active like for example drugs 1. When inserted into the body, a local 
tissue inflammatory reaction called foreign body reaction is induced 2. This reaction may 
either favour or adversely affect the tissue repair process. 
Cellulose and its derivatives are well tolerated by most tissues and cells 3-5. These non-
toxic materials have good biocompability, therefore, they offer several possibilities in 
medical applications. Regenerated cellulose sponges have also been used in experimental 
surgery for decades as it does not affect the healing process, but acts as a chemoattractant 
inducing cells involved in the repair process to migrate towards it 6-8.  
We have studied different biomaterials including cellulose in search for an optimal bone 
substitute. In bone defects, regenerated cellulose supported with cotton fibres was shown to 
allow new bone in-growth to some degree 9-11. Oxidation with periodate and hydrogen 
peroxide, or carbamination further improved its biocompability but not enough to be used 
as bone substitutes. We also expected to increase the osteostimulating property of 
regenerated cellulose by coating it with a silica-rich hydroxyapatite (HA) as it resembles the 
mineral composition of bone. To our disappointment, the HA-coated cellulose did not 
promote bone formation but favoured instead inflammation and fibroplasia. Since the bone 
implant study revealed unexpectedly an enormous ability of the HA-implants to induce 
granulation tissue, the coated cellulose was tested subcutaneously as well. These studies 
showed that the HA-coated cellulose not only attracted inflammatory cells but also bone 
marrow-derived progenitor cells of both haematopoietic and mesenchymal origin (see box 
1). In this chapter, we will discuss cellulose as implant material with emphasis on the cell 
guiding properties of regenerated cellulose coated with silica-rich HA. 
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2. Cellulose for medical applications and as a tissue engineering matrix  
Cellulose, the most common organic compound on Earth, is degraded by microbial 
enzymes. Animal cells cannot cleave the β(1→4)-bond between the two glucose moieties in 
cellulose. Thus, cellulose degradation in tissues takes place by a slow non-enzymatic 
hydrolysis of the β(1→4)-bond and therefore cellulose can be regarded as an almost stable 
matrix. Despite this, cellulose and its derivatives are well tolerated by cells and tissues and 
induce a moderately strong foreign body reaction in the tissue [3-8].  
 
BOX 1. ADULT BONE MARROW-DERIVED STEM CELLS 
Adult stem cells are immature cells, dispersed in tissues throughout the body after 
development. Like all stem cells, they are capable of either making identical copies of 
themselves or to differentiate depending on their local environment into mature cell types 
with characteristic morphology and function. Stem cells usually generate an intermediate, 
partly differentiated, cell type, called precursor or progenitor cell, before they achieve their 
fully differentiated state. Adult stem cells are rare, however. Their primary functions are to 
replenish dying cells, and with limitations, to regenerate damaged tissues. 
The best characterised adult stem cells are those found in the bone marrow, which 
provides a unique niche for haematopoietic stem cells (HSCs) and the mesenchymal stem 
or stromal cells (MSCs). HSCs are responsible for the production and replacement of all 
blood cells during the entire lifetime 13. The earliest haematopoietic precursor, the 
haemangioblast, is not only a precursor of haematopoietic cell lineages but also of cells that 
line all blood vessels and lymphatics, namely the endothelial cells 14. 
Mesenchymal stromal cells are a heterogenous population of stem/progenitor cells able to 
differentiate into several cell types such as chondrocytes, osteocytes, fibroblasts, myocytes, 
adipocytes, epithelial and neuron-like cells. When stimulated by specific signals, these cells 
can be released from their niche in the bone marrow into circulation and recruited to the 
target tissues where they undergo in situ differentiation and contribute to tissue 
homeostasis and repair 15. MSCs also secrete factors that promote survival and 
differentiation of endogenous cells as well as angiogenetic factors essential for blood vessel 
formation. MSCs possess remarkable immunosuppressive properties and can inhibit the 
proliferation and function of the major immune cell population 16, 17 as well as 
antimicrobial properties 18. Furthermore, these multipotential stromal stem and 
progenitor cells at different stages of maturation contribute to the formation of HSC stem 
cell niche and play a critical role in haematopoiesis 19.The characteristic of MSCs makes 
these cells exceptionally suitable for various therapeutic possibilities such as supporting 
tissue regeneration, correcting inherited disorders, dampening chronic inflammation, and 
delivering biological agents 15. 
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Cellulose is non-toxic and has good biocompability, therefore, it offers several possibilities 
in medical applications. Cellulose and its derivatives are used, among other things, as 
coating materials for drugs, additives of pharmaceutical products, blood coagulant, 
supports for immobilized enzymes, artificial kidney membranes, stationary phases for 
optical resolution, in wound care and as implant material and scaffolds in tissue engineering 
3, 12. 
2.1. Regenerated cellulose 
Cellulose sponges can be manufactured by adding supportive strengthening fibres (8-10 
mm long cotton fibres; about 20% of the weight of the cellulose) and sodium sulphate 
crystals as pore forming material to a cellulose viscose (sodium xantogenate) solution (4-6 g 
cellulose/100 g viscose). The cellulose is regenerated by heating the solution in a water bath 
after which the sponge is washed with hot water, treated with a dilute acid and sodium 
hypochlorite bleaching solution, and finally washed repetitively in distilled water before 
drying and sterilisation 20, 21. When inserted subcutaneously, a vital and well 
vascularised repair tissue, called granulation tissue, grows rapidly into this cellulose 
sponge. Due to this good granulation tissue formation ability, cellulose sponges have been 
used in experimental surgery for decades 6, 7, 22 and the subcutaneous implantation of the 
cellulose sponge is widely accepted method for wound healing (see box 2) studies 8, 23. 
Several cellulose products for wound healing purposes (e.g. Cellospon®, Cellstick®, 
Sponcal®, Visella®, and Absorpal®) are commercially available. These products are made 
from the sponge form viscose cellulose and have homogenous porous structure, 
characterized by thin pore walls with one or more inter-pore openings. They are elastic and 
can be compressed and expanded repeatedly with no damage to their internal structure, 
hence providing free entrance for the invading cells to the inner parts of the sponge 24.  
Host reactions following implantation of biomaterials include injury, blood-material 
interactions, provisional matrix formation, inflammation, granulation tissue development, 
foreign body reaction, and fibrosis/fibrous capsule development 25. When implanted 
subcutaneously, a blood-material interaction occurs with protein adsorption to the cellulose 
sponge and a blood-based transient provisional matrix, a blood clot; is formed on and 
around the sponge. The platelets, originated from the injured blood vessels, not only 
participate to haemostasis but also liberate bioactive agents like cytokines and growth 
factors that will attract inflammatory and phagocytosing cells. The first cells to arrive are 
polymorphonuclear leucocytes, i.e. neutrophils, which are characteristic for the acute 
inflammatory response. These cells secrete pro-inflammatory cytokines that, in turn, attract 
circulating monocytes, which are activated and converted in the tissue to macrophages that 
kill bacterial pathogens, scavenge tissue debris and destroy remaining neutrophils. 
Biomaterial surface adherent macrophages can also fuse to form multinucleated foreign 
body giant cells. In their attempt to phagocytose the biomaterial, adherent macrophages 
become active 25. By releasing a variety of chemotactic, neovasculogenic and growth 
factors that stimulate cell migration, proliferation and formation of new blood vessels and 
tissue matrix, macrophages mediate the transition from the inflammatory phase to the 
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proliferative phase. During the proliferative phase, the provisional extracellular matrix in 
the cellulose sponge is gradually replaced with granulation tissue, which is formed from 
infiltrated mature fibroblasts and rapidly proliferating mesenchymal stromal cells (MSCs) 
differentiating to fibroblasts in situ. The newly formed extracellular matrix is rich in blood 
vessels, which carry oxygen and nutrients to maintain the metabolic processes. The sponge 
is surrounded by a well-vascularised fibrous capsule, which becomes somewhat thinner 
during the final remodelling phase [38].  
Similar biocompatible regenerated cellulose developed for wound healing studies has also 
been tested as a scaffold for cartilage tissue engineering. Although the cellulose sponge 
provided a non-toxic environment for cartilage cells, the construct remained soft and lacked 
the extracellular matrix composition typical for normal articular cartilage 26. When 
implanted into bone defects, regenerated cellulose strengthened by cotton fibres allowed 
new bone in-growth to some extent 9-11.  
2.1.2. Hydroxyapatite-coating of regenerated cellulose 
The number of cells and tissue in-growth are affected to a certain limit by the porosity, size 
of pores, and the thickness of the pore walls of the cellulose sponge 8. We hypothesised 
that coating the regenerated cellulose with hydroxyapatite (HA) that resembles the mineral 
composition of bone, would improve its bone forming properties. The mineral originated 
from a specific bioactive glass, S53P4 (23% Na2O, 20% CaO, 4% P2O5, 53% SiO2) that has a 
good osteoconductivity and is in clinical use 27-32. However, glass as such, is difficult to 
trim to the desired size and form. Furthermore, it is brittle and fragile, and therefore, not 
suited in sites subjected to load like in femoral and tibial bone defects. 
In our studies, the calcium phosphate layer was precipitated on cellulose sponges (10 x 100 x 
100 mm) with average pore sizes between 50 and 350 m by the biomimetic method of 
Kokubo et al 33. Mineralisation was initiated in 500 ml of sterile simulated body fluid 
(SBF) supplemented with a 2.0 g of the bioactive glass at 37˚C for 24h and was then grown in 
500 ml sterile 1.5 x SBF for 14 days at the same temperature under continuous shaking. The 
SBF solution was changed every second day. The formed calcium phosphate layer rich in 
silica was verified by scanning electron microscope (figure 1) and characterised with Fourier 
transform infrared spectroscopy 11. (1 x SBF = 136.8 mM NaCl, 4.2 mM NaHCO3, 3.0 mM 
KCl, 1.0 mM K2HPO4 x 3H2O, 1.5 mM MgCl2 x 6H2O, 2.5 mM CaCl2 and 0.5 mM Na2SO4, pH 
7.4; ion concentration close to that of human plasma) 
Sterile HA-cellulose and untreated cellulose sponges, sized 2.3 x 3 x 8 mm, were implanted 
into femoral bone defects of male rats aged 10-13 weeks (for further details see 11) and 
were followed up for 52 weeks. The implants were analysed histologically and with 
biochemical and molecular biologic methods. The HA layer did not improve the bone in-
growth into the cellulose sponge. In fact, the new bone was instead mainly formed beneath 
the implant at the bottom of the defect leaving the implant filled with a well vascularised 
fibrous tissue rich in inflammatory cells (figure 2). The inflammatory reaction was much 
stronger than in the uncoated cellulose indicated by the larger number of inflammatory cells  
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Figure 1. SEM micrograph of regenerated uncoated and HA-coated cellulose sponges (bar = 50 m). 
The hydroxyapatite layer was initiated in sterile 1 x SBF with bioactive glass at 37 °C for 24 h and was 
then grown in sterile 1.5 x SBF at the same temperature for 14 days under continuous shaking.  
 
Figure 2. HA-coating of cellulose prevents bone in-growth. One year after implantation into rat femoral 
bone defect, new bone (nb) growth is mainly observed beneath (arrows) the HA-implant (a), which has 
been pushed out from the defect area. The HA-implant itself (b) is mostly filled with soft connective 
tissue containing abundant giant cells (arrow heads). Uncoated cellulose implant (c) allows new bone 
in-growth and the non-ossified parts contain less inflammatory cells. (a and c; van Gieson stain; b and d 
haematoxylin-eosin stain; cf = cellulose fragment; scale bar = 100 m, modified from 11). 
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including macrophages and foreign body cells, which also is a sign of chronic inflammation. 
Activated inflammatory cells produce many pro-inflammatory bioactive agents, such as 
tumour necrosis factor-alpha (TNF-which is known to interfere with the bone specific 
transcription factor Cbfa1 and to depress the function of differentiated osteoblasts 34,35. 
Continuous exposure to these agents may, thus, inhibit differentiation of the progenitor cells 
into bone forming osteoblasts explaining, as least partly, the less osteoid tissue in HA-coated 
cellulose implants. Furthermore, the HA layer did intensify the attachment of transforming 
growth factor beta 1 (TGF) 11, a growth factor involved in fibroplasia. Hence, the HA 
surface did not offer any advantages in comparison with untreated cellulose in cortical bone 
defect healing. 
2.2. The effect of increased biodegradability of cellulose 
Another approach to improve the biocompatibility of cellulose was to alter its chemical 
structure in order to increase its biodegradability. The mild bleaching and oxidation of 
regenerated cellulose with sodium hypochlorite carried out during the preparation of 
cellulose sponge does not cleave the glucose ring and the resultant cellulose is not 
biodegradable, which probably prevented complete ossification of the implanted sponge. 
Therefore, in the search for suitable bone defect fillers, we extended the material 
development with a two sequential oxidation steps. Firstly, the cellulose was oxidated by 
periodate for 1-3 hours. This treatment opens some glucose molecules and should 
theoretically make them more susceptible to glucosidases and other enzymes capable for 
carbohydrate degradation. Excess periodate was washed by ascorbate or thiosulphate and 
water before the second oxidation by hydrogen peroxide (H2O2) for 3 or 4 hours. As the 
oxidation reactions were not complete, the resultant materials are combinations of 2,3-
dialdehyde and 2,3-dicarboxyl celluloses. The biogradability of the celluloses was tested in 
SBF for 7, 15 and 30 days. Oxidations for 3 h in periodate followed by 4 h in H2O2 turned out 
to be the best combination as 70% of the material was dissolved. Therefore, this material was 
used for further testing. No cytotoxicity was observed in fibroblast cultures. The material 
has to be sterilised by 70-95 % ethanol or ethylene oxide because autoclaving destroys the 
porous structure of the scaffolds.  
The results of the bone implantation experiments (figure 3 a, b) showed that oxidised 
scaffolds were flattened, their pores had disappeared and the material was completely 
replaced by cells so that no visible cellulose fibrils were observed in the implantation sites. 
The degradation was not complete as the phagocytosing cells were full of homogenous 
material. It is conspicuous, however, that no giant cells were observed in the oxidised 
samples, whereas normal cellulose always induces a number of foreign body giant cells. If 
the sponges were oxidised more extensively their structures collapsed and the material 
could not be used for implantation. The implanted scaffolds did not show, on the other 
hand, any significant bone in-growth. Instead they consisted of cell masses that 
histologically were strikingly homogeneous. New bone had been grown on the opposite site 
of the implant strengthening the defect site. Despite improved biodegradability, oxidised 
cellulose was considered to have no value as a bone substitute.  
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Figure 3. Oxidations with periodate and H2O2 increase the biocompability and degradation of cellulose. 
Oxidised cellulose (a, b) allows new bone (nb) formation when implanted into femoral bone (fb) defects 
of rat. (cs = cellulose scaffold, bm = bone marrow, m=muscle overlaying the implant site, arrow heads 
point at osteoblasts lining the new bone; haematoxylin-eosin stain; scale bars = 100 m (a), and 25 m 
(b)). 
Biodegradation of cellulose can also be improved by treating it with urea. The resultant 
carbamino cellulose showed increased solubility that could be regulated by the duration of 
treatment. The fundamental aim was to develop material that could be used as a vehicle for 
drugs in tablets, or perhaps for subcutaneous long-lasting administration of drugs. Small, 
round or oval cellulose pearls with 50-500 m diameters can be manufactured from regular 
or carbamino cellulose by dropping viscose into a solution containing 100 g H2SO4 and 200 g 
Na2SO4/l at 20°C followed by centrifugation 36. Four and six per cent viscose solutions 
were used to make the 0.5 mm diameter cellulose pearls. The material was collected, washed 
with distilled water and 5g H2SO4/l and dried for 24 hours at 40°C. Sterilisation was carried 
out by autoclaving or with 70% ethanol.  
For implantation studies, several pearls were glued together with alginate 37 in moulds. 
The results from the subcutaneous implantation experiment (Figure 4 a, b) were 
encouraging as implanted 4% cellulose pearls were infiltrated with new granulation tissue 
and most of the pearls showed signs of nearly complete degradation where as 6%-pearls 
were more resistant during the observation period of two weeks. Intramedullary 
implantation into rat femoral bone (figure 3 c-e) showed similar behaviour: many of the 4 %-
pearls were infiltrated by new granulation tissue and some were surrounded by new 
osteoid tissue. There was some variation in the degree of degradation; while some pearls 
had been digested completely, some remained almost intact. No foreign body giant cells 
were observed, however. We do not know whether alginate surroundings affected the 
degradation of pearls in the bony environment, but to make the carbamino cellulose more 
useful in medical applications, the structure should be further altered to become even more 
vulnerable to hydrolytic enzyme attacks, especially if used for subcutaneous administration 
of drugs. 
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Figure 4. Tissue reactions of carbamino cellulose two weeks after implantation. Subcutaneously 
implanted 6%-cellulose pearls (p) stayed intact and showed only modest degradation (a), whereas b) 
4%-cellulose pearls were degraded and infiltrated with new granulation tissue (gf). Similar behaviour 
was observed in bone implants: c) 6%-cellulose pearls were surrounded by a thin connective tissue 
capsule (arrow) whereas about half of the b) 4%-cellulose pearls were partially degraded and 
surrounded by bone (nb) or a thin osteoid layer (ol) even in the bone marrow (bm) area. (van Gieson 
stain; equal magnifications; scale bar 200 m).  
2.3. The biological effect of subcutaneously implanted hydroxyapatite-coated 
cellulose  
The bone defect study showed that HA-coated cellulose favoured rapid fibrous tissue 
proliferation instead of bone formation 11. Therefore, it was considered to have no value as 
a bone replacement material but might be useful in other applications in which accelerated 
granulation tissue formation is needed. Subcutaneously (figure 5 a, b) implanted silica rich 
HA-implants showed a massive inflammatory reaction with an intense foreign body 
reaction and increased invasion of fibrovascular tissue already 1-3 days after implantation. 
Such strong tissue reaction was not seen with any other subcutaneously implanted cellulose 
sponge. Tissue growth into uncoated regenerated cellulose was much slower and took place 
mainly on their surface (figure 6). 38  
Subcutaneously implanted HA-sponges activate the inflammatory response and the 
secretion of cytokines and growth factors important to wound healing, such as TGF-1, 
TNF-, vascular endothelial growth factor (VEGF) and platelet derived growth factor A 
(PDGF-A) The long-term study revealed, however, that the excessive connective tissue  
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Figure 5. a). A schematic presentation of the subcutaneous implantation model used in our studies. 
Two midline incisions were made on the back of the rats, and sterilised, moistened sponge implants (10 
x 5 mm) were inserted bilaterally into subcutaneous pockets under general anaesthesia. b). 
Subcutaneously implanted cellulose sponges 7 days after implantation. HA-coated implants are darker 
in colour as a sign of high cellularity and rich neovascularisation, whereas the uncoated implants are 
pale.  
 
Figure 6. The HA-coating accelerated tissue growth into subcutaneously implanted cellulose sponges 
as well as the inflammatory response and blood vessel formation. a) Haematoxylin-eosin–stained 
sections 1 (upper), 3 (middle), and 7 (lower) days after implantation. The arrows in HA-coated sponges 
point at the border between the implant and the surrounding capsule (scale bar = 100 m). b) HA-
coated sponges contain large clusters (arrows) of accumulated macrophages (brownish coloured cells). 
Macrophages favour gathering near to cellulose fibres (arrow head) (day 5; scale bar = 50 m). c) More 
blood vessels, as indicated by CD31-staining, can bee seen in 5-day-old HA-coated sponge compared to 
uncoated one (scale bar = 50 m). 
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formation, which is histologically normal, does not disturb the animals in any way. After 14 
days postoperatively, the foreign body reaction in HA-coated sponges starts to diminish. At 
one month, the difference between the HA-coated and uncoated cellulose had levelled off 
and at the end of the study, at one year no obvious histological difference between the 
coated and uncoated were detected (figure 7). 38 
 
 
Figure 7. Histology of subcutaneous cellulose implants. a) At 14 days HA-coated sponge is filled with 
granulation tissue (van Gieson-stained whole implants, scale bar = 1000 m). b) Haematoxylin-eosin-
stained sections one and three months after implantation, scale bar 100 m. c) At one year no significant 
difference can be observed between HA-coated and uncoated sponges (van Gieson-stained whole 
implants, scale bar = 1000 m. Modified from 38).  
2.3.1. Cell trafficking and homing to regenerated cellulose  
Cellular movement and re-localisation are essential for many fundamental physiologic 
properties, not only during embryonic development, but also during wound healing and 
organ repair. At the wound site, local and infiltrated cells release chemokines that recruit 
blood-circulating stem and progenitor cells. These bioactive agents also increase bone 
marrow cell mobility, thus facilitating cell mobilisation into the peripheral blood and 
consequently into the sites of wound healing 39. Stromal-derived factor-1 (SDF-1) is one 
powerful chemokine in stem cell trafficking that regulates both haematopoietic, endothelial 
and mesenchymal progenitor cells. The biological effects of SDF-1 are mediated by the 
chemokine receptor CXCR4 40-43. During the early stages of wound healing, SDF-1 seems 
to be up-regulated by the influence of pro-inflammatory factors like TNF- which creates a 
SDF-1 concentration gradient that triggers the recruitment of CXCR4-expressing cells from 
the blood stream to the site of injury, where these cells further differentiate into other 
functional repair cells 44.  
Mineralised cellulose implant not only attracts more inflammatory cells than uncoated 
cellulose but also circulating bone marrow-derived stem cells of both haematopoietic and 
mesenchymal origin 45. SDF-1 expression (GEO series accession no. GSE19748 and 
GSE19749; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSExxx) is upregulated in 
HA-sponges together with its receptor CXCR4 (figure 8). This strongly indicates that the 
HA-coated implant has a better homing capacity of circulating bone marrow-derived stem 
cells than the uncoated one. 
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Figure 8. HA-coated cellulose contain large amount of CXCR4-positive cells. Numerous clusters (arrow 
heads) of and individual CXCR4-positive (brownish coloured) cells are detected throughout the HA-
coated sponge at day 7.  
Haematopoietic stem cells seem to be the first stem cells to invade the empty centres of the 
HA-coated cellulose implants (figure 9 a-c). The more abundant occurrence of HSCs is most 
probably responsible for the augmented blood vessel formation in HA-coated cellulose. The 
earliest haematopoietic precursor, the haemangioblast, is namely the precursor for both 
haematopoietic and endothelial cell lineages, not only during embryogenesis but also in 
adults 14, 46. The haematopoietic progenitors, especially in the HA-coated implants, were 
located in close contact with the cellulose fragments (figure 10 a). Hence, the coating of 
cellulose with HA creates an environment that facilitates stem cell homing more efficiently 
than uncoated cellulose. In the bone marrow, undifferentiated HSCs are detected near the 
inner surface of the medullary cavity, i.e. the endosteum, in the so-called endosteal stem cell 
niche. At this site, the bone is in constant turnover: bone is formed by the osteoblasts and 
removed by specific macrophages, the osteoclasts. Due to bone degradation, soluble calcium 
ions (Ca2+) are released into the bone marrow fluid. Various cells, including primitive HSCs, 
respond to extracellular ionic calcium concentrations through a calcium sensing receptor, 
CaSR. This receptor seems to have a function of holding HSCs in close physical nearness to 
the endosteal surface 47. The mineral layer on the cellulose resembles that of bone. When 
the numerous foreign body giant cells/macrophages gathered around the mineralised 
cellulose try to get rid of the foreign material, Ca2+ is released generating a beneficial milieu 
for the primitive HSCs as it resembles the endosteal stem cell niche in the bone marrow. 
This theory is supported by the numerous CaSR-positive cells near the mineralised cellulose 
fibres, in the same areas as cells positive for CD34, a common marker for endothelial cells, 
are observed. These cells are not only found in the granulation tissue but also in the central 
parts of the implant. Similar cells are seen in uncoated cells, but in remarkably less quantity 
(figure 9 d-e).  
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Figure 9. Stem cells are located near the cellulose fragments. a) General histology showing cells 
gathering around the cellulose fragments (cf) at day 7. The arrows point at pores (scale bar = 50 m). b). 
HA-coated implants contains numerous cells (arrowhead) positive for c-kit, a marker for premature 
cells (day 7; scale bar = 25 m). c) Small rounded cells (arrowhead) positive for CD34, a commonly used 
marker for HSCs (day 7; scale bar = 25 m). More CaSR-positive cells (red fluorescence) are observed in 
HA-coated implants at day 7 (d) than in uncoated (e) sample (scale bar = 25 m). 
In the cellulose implants, mesenchymal stem cells are mainly found in the forming 
granulation tissue 45 in line with the fact that these primitive cells home to the wound site 
and differentiate into connective tissue cells that produce the extracellular matrix of the 
granulation tissue 48. In addition, MSCs secrete signals that limit systemic and local 
inflammation, decrease apoptosis in the threatened tissue, stimulate neovascularisation, 
activate local stem cells, modulate the immune cells, and exhibit direct antimicrobial activity 
18, 49, 50. Therefore, the more abundant occurrence of MSCs in the HA-coated cellulose 
sponge most probably contribute to the enhanced blood vessel formation compared to 
uncoated cellulose and to the declining of the foreign body reaction during the second week 
of implantation. MSCs also secrete many cytokines that stimulate haematopoiesis, mainly 
the myeoloid cell lineage, but MCSs seems to have a supportive effect on erythropoiesis, the 
process of red blood cell formation, as well 51. 
2.3.2. Experimental granulation tissue expresses haemoglobin 
An unexpected finding was that the granulation tissue induced by cellulose sponge contains 
haemoglobin producing glycophorin A-positive cells (figure 10 a-d) indicating that the 
haematopoietic precursor cells are also able to differentiate into the erythropoietic lineage 
52. This, in turn, suggests that this repair tissue is capable of making blood. In healthy 
adults, globin has been considered to be expressed only in the bone marrow area by 
immature erythropoietic precursors. When the mature red blood cell or erythrocyte emerges 
from the bone marrow, it has lost its nucleus, ribosomes and mitochondria, which means 
that the cell is no longer capable of gene expression. As in bone marrow, where erythroid 
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progenitors mature in association with macrophages 53, 54, the plentiful macrophages, 
especially in the HA-coated implants, might further back up the erythropoietic 
differentiation of HSCs in the granulation tissue. Microarray data (GEO series accession no. 
GSE19748 and GSE19749; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSExxx) 
revealed many genes related to erythropoiesis like erythropoietin and its receptor EpoR, the 
transciption factors Hif-1gata-1 and -2, and particularly Alas2, which is exclusively 
expressed in developing red blood cells called erythroblasts and is required for the 
expression of -globin 55. 
Haemoglobin has traditionally been thought to serve as the main oxygen transporter in 
erythrocytes. Many studies, including ours 56-65, show, however, that haemoglobin 
expression is much more versatile than previously has been assumed. During granulation 
tissue formation in the cellulose sponges, the haemoglobin expression pattern showed a 
biphasic pattern 52. The first peak appeared during the most intense inflammatory 
response in the initiation of the healing process before invasion of HSCs, indicating that also 
another cell type is participating in the haemoglobin expression. Since active macrophages 
are known to express globin 64, these cells (figure 10 e-g) are most likely responsible for 
the early globin expression in the granulation tissue. In macrophages, the globins are most 
probably involved in processes different from oxygen transport and delivery to tissues. 
There is accumulating evidence that haemoglobin also binds, stores and transports nitric 
oxide. Nitric oxide is an important gaseous signalling molecule in wound healing 66 
involved, among other things, in the formation of granulation tissue and new blood vessels 
67-69. While nitric oxide is a prerequisite for successful wound healing, an excess of this 
signalling molecule may be as harmful as its underproduction 67. The fact that an intense 
expression of inducible nitric oxidase synthase (iNOS), an enzyme that catalyses the  
 
Figure 10. Double staining confirmed different haemoglobin positive cell types in cellulose implants. 
The granulation tissue in cellulose sponges contains haemoglobin (a) -producing glycophorin A-
positive cells (b) implying that haematopoietic precursor cells are able to differentiate into red blood 
cells. c) Merged image of haemoglobin- and glycophorin A-positive cells. d). Red blood cells in a blood 
vessel in the capsule area of HA-implant; haemoglobin (upper) positive, glycophorin A (middle) and 
merge image (lower). e) CD-68 positive cells indicating macrophages. The same cells are also positive 
for haemoglobin (f). (g) Merged image of CD-68- and glycophorin A-positive cells (scale bar 20 m, 
modified from 52). 
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formation of nitric oxide, which reflects the production of nitric oxide observed in 3-day-old 
HA-implant, but not at day 10 52, coincides with the strong inflammatory reaction that 
starts to decline during the second week of implantation 38. The production of 
haemoglobin during this phase might eliminate the excess nitric oxide and prevent its 
negative effect on matrix deposition, neovascularisation and apoptosis. In uncoated 
cellulose implants, iNOS is detected at day 10, which supports the observation of slower 
sequence of events in the granulation tissue formation in these uncoated implants 
3. Conclusions and future perspectives 
Regenerative medicine involves tissue formation and healing in order to restore the 
functionality of damaged organs or tissues. As tissue repair and regeneration after injury 
involve the selective recruitment of circulating or resident stem cell populations, stem cell 
therapy is often employed as one mean to promote tissue regeneration. Its success might, 
nevertheless, be complicated by strong immune-rejection of transplanted cells or shortage of 
autologous cell supply. Furthermore, if a scaffold, with or without bioactive agents, is used 
to administrate the stem cells, poor integration between the scaffold/implant and the host 
tissue might affect the outcome. 
An interesting tissue engineering concept is cell guidance aimed at total in vivo tissue 
engineering without the need of adding bioactive agents or cells. Numerous studies have 
shown that cellulose itself functions as a chemoattracant and is able to stimulate granulation 
tissue formation. Uncoated cellulose sponge has been tested in treatment of chronic leg 
ulcers (Pajarre, unpublished data) and in severe burn injuries (Lagus, unpublished data) in 
the 1990’s with good results. The cellulose sponge adsorbs debris and bacteria from the 
wound site and attracts inflammatory cells. In these cases, a short-term, powerful 
inflammatory response is actually necessary. After cleaning the wound bed, the cellulose 
induces vital granulation tissue formation, and smoothens and prepares the wound bed for 
successful skin transplantation. 
The fascinating property of HA-coated cellulose sponge is its ability to even further amplify 
the healing mechanisms of the body. The HA-coated cellulose acts as a cell-guiding material, 
attracting stem cell reserves. The novel finding of haemoglobin expression during wound 
healing brought into daylight new data concerning blood formation and development of 
neovascularisation. The clinical relevance of this is the production of more vascularised 
granulation tissue in the critical early phases of wound healing.  
We hypothesise that the cell guiding property of the HA-coated cellulose is due to the 
combination of silica and calcium phosphate. Preliminary results (Stark et al, unpublished) 
from our on-going study show that a mineral layer induced by dipping the cellulose sponge in 
a calcium phosphate solution has not the same beneficial feature on granulation tissue 
formation (not shown) than the mineral layer induced by the bioactive glass in simulated body 
fluid. Although there was a somewhat stronger inflammatory reaction when compared to 
uncoated cellulose it was not as intense as in HA-coated cellulose. Our deduction is that the 
silica elevates the inflammatory reaction with enhanced level of bioactive agent production 
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that attracts more circulating bone marrow-derived progenitor cells whereas the calcium 
phosphate layer contributes to hastened stem cell homing to the cellulose sponge. 
Due to the cell-guiding property of silica rich HA-coated regenerated oxidised cellulose in 
combination with the capacity to promote proliferation of richly vascularised connective 
tissue, this material might have potential in clinical situations when rapid granulation tissue 
growth is needed as in treatment of poorly healing wounds. The contact with the HA-
cellulose sponge would be local and temporary, therefore minimizing any possible 
disadvantages. In addition to safety issues, the manufacturing process of coating cellulose 
with HA is relatively simple and cheap, and the HA-coated cellulose sponge is easy to 
handle, form and sterilise. 
 
BOX 2. BIOLOGY OF WOUND HEALING 
Wound healing is a complex and dynamic process of restoring cellular structures and 
tissue layers in the body. The physiological and coordinated response to injury is 
practically similar in all tissues and involves three distinct but overlapping phases that can 
be divided into inflammation, new tissue formation and remodelling 70. In turn, these 
three phases comprehend coordinated series of events that includes chemotaxis, 
phagocytosis, neocollagenesis, collagen degradation, and collagen remodelling. 
Furthermore, neovascularisation, epithelisation, and the production of new 
glycosaminoglycans (GAGs) and proteoglycans are vital during wound healing process. 
The key initiators of the healing process are the platelets, which within minutes after injury 
aggregate and form fibrin clot in aim to control bleeding. In addition to their important 
role in hemostasis, platelets also liberate growth factors that will attract inflammatory and 
phagocytosing cells. The first cells to arrive are polymorphonuclear leucocytes, i.e. 
neutrophils that secrete proinflammatory cytokines. Shortly thereafter circulating 
monocytes will appear, are activated and converted in the tissue to macrophages that kill 
bacterial pathogens, scavenge tissue debris and destroy remaining neutrophils. 
Macrophages also mediate the transition from the inflammatory phase to the proliferative 
phase by releasing a variety of chemotactic agents and growth factors that stimulate cell 
migration, proliferation and formation of tissue matrix.  
The second phase of wound healing is often called the proliferative phase or the 
granulation tissue formation phase. This stage starts normally two to three days after 
injury and lasts approximately two to three weeks. During this phase the provisional 
extracellular matrix is gradually filled with granulation tissue. The phenomenal feature is 
to diminish the area of tissue loss by contraction and fibroplasia. The infiltrated cells 
produce a new extracellular matrix, rich in blood vessels, which carry oxygen and 
nutrients to maintain the metabolic processes. Although new collagen and other 
extracellular matrix proteins are continuously actively synthesised, the earlier formed 
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fibrin clot is enzymatically degraded. This process allows the proceeding of re-
epithelisation that is needed to control the growth of the repair tissue and wound closure. 
The proteolytic activity is also a prerequisite of the neovascularisation. 
Usually by three weeks after injury, new tissue formation starts to decrease, and the 
emphasis of wound healing process turns to the remodelling and maturation. The main 
objective of this phase is to achieve maximum tensile strength by reorganisation, 
degradation and re-synthesis of the extracellular matrix. This final process may last even 
several years, before the new granulation tissue rich in cells and vascular capillaries has 
matured into a relatively acellular and avascular scar that lacks appendages, including hair 
follicles, sebaceous glands, and sweat glands 70. 
 
apoptosis programmed cell death 
biocompability the ability of a material to perform with an appropriate host 
response in a specific application 
chemoattracant a chemical (chemotactic) agent that induces an organism or a cell to 
migrate toward it 
chemokine small chemotactic pro-inflammatory cytokine 
chemotaxis directional movement in response to the influence of chemical 
stimulation 
cytokine a small cell-signalling protein molecule secreted by numerous cells; 
involved in intercellular communication 
endosteum a thin layer of connective tissue lining the medullary cavity of bone 
fibroplasia the process of forming fibrous tissue 
growth factor  a naturally occurring substance capable of stimulating cell growth, 
proliferation and cell differentiation  
haemostasis the process that causes bleeding to stop 
haematopoiesis production of all types of blood cells including formation, 
development, and differentiation of blood cells 
phagocytosis  an important defence mechanism against infection by 
microorganisms (e.g. bacteria) and the process of removing cell 
debris (e.g. dead tissue cells) and other foreign bodies 
receptor a structure on the surface of or inside a cell that selectively receives 
and binds a specific substance 




molecules, usually proteins, which are involved in regulating gene 
expression 
Table 1.  
 
Cellulose - A Biomaterial with Cell-Guiding Property 99 
Author details 
Miretta Tommila, Anne Jokilammi, Risto Penttinen and Erika Ekholm* 
Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland 
Miretta Tommila 
Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Turku University 
Hospital, Turku, Finland 
Acknowledgement 
Johanna Holmbom, Christoffer Stark and Ville Peltonen are acknowledged for technical 
assistance. We thank Bruno Lönnberg, Kurt Lönnqvist and the Cellomeda Ltd. for various 
celluloses and the Swedish Cultural Foundation for supporting our ongoing cellulose 
study. 
4. References 
[1] Buddy D Ratner, Allan S Hoffman, Frederick J Schoen, Jack E Lemons (2004) 
Biomaterials Science: An Introduction to Materials in Medicine. San Diego, London. 
Elsivier Academic Press. 864 p. 
[2] Anderson JM, Jones JA (2007) Phenotypic dichotomies in the foreign body reaction. 
Biomaterials. 28: 5114-5120. 
[3] Miyamoto T, Takahashi S, Ito H, Inagaki H (1989 Tissue compability to cellulose and its 
derivatives. J. biomed. mat. res. 23: 125-133. 
[4] Barbié C, Chaveaux D, Barthe X, Baquey C, Poustis j (1990) Biological behavior of 
cellulosic material after bone implants: Preliminary results. Clin. mat. 5: 251-258. 
[5] Kino Y, Sawa M, kasai S, Mito M (1998) Multiporous cellulose microcarrier for 
the development of hybrid artificial liver using isolated hepatocytes. J. surg. res. 
79¸71-76. 
[6] Viljanto J, Kulonen E (1962) Correlation of tensile strength and chemical composition in 
experimental granuloma. Acta pathol. microbial. scand. 52: 120-126. 
[7] Raekallio J, Viljanto J (1975) Regeneration of subcutaneous connective tissue in children. 
A histological study with application of the CELLSTICK device. J. cutan. pathol. 2: 191-
197. 
[8] Pajulo Q, Viljanto J, Lönnberg B, Hurme T, Lönnqvist K, Saukko P (1996) Viscose 
cellulose sponge as an implantable matrix: changes in the structure increase the 
production of granulation tissue. J. biomed. mater. res. 32: 439-446. 
[9] Märtson M, Viljanto V, Laippala P, Saukko P (1997) Bone formation in implant is a 
milieu dependent phenomenon. An experimental study with cellulose sponge in rat. 
Surg. childh. intern. 5: 251-255. 
                                                                 
* Corresponding Author 
 
Cellulose – Medical, Pharmaceutical and Electronic Applications 100 
[10] Märtson M, Viljanto J, Hurme T, Saukko P (1998) Biocompatibility of cellulose sponge 
with bone. Eur. surg. res. 30: 426-432. 
[11] Ekholm E, Tommila M, Forsback AP, Märtson M, Holmbom J, Ääritalo V, Finnberg C, 
Kuusilehto A, Salonen J, Yli-Urpo A, Penttinen R (2005) Hydroxyapatite coating of 
cellulose sponge does not improve its osteogenic potency in rat bone. Acta biomater. 1: 
535-544. 
[12] Hoenich N 2006 Cellulose for medical applications: past, present, and future: Available: 
http://ojs.cnr.ncsu.edu/index.php/BioRes/article/viewFile/BioRes_01_2_270_280_Hoenic
h_Cellulose_Medical_Review/26. 
[13] Boisset JC, Robin C (2012) On the origin of hematopoietic stem cells: progress and 
controversy. Stem cell res. 8: 1-13. 
[14] Cao N, Yao ZX (2011) The hemangioblast: from concept to authentication. Anat. rec. 
(Hoboken). 294: 580-588. doi: 10.1002/ar.21360 
[15] Liu ZJ, Zhuge Y, Velazquez OC (2009) Trafficking and differentiation of mesenchymal 
stem cells. J. cell biochem. 106: 984-991. 
[16] Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. 
Nat. rev. immunol. 8: 726-736. 
[17] Shi M, Liu ZW, Wang FS (2011) Immunomodulatory properties and therapeutic 
application of mesenchymal stem cells. Clin. exp. immunol. 164:1-8. DOI:10.1111/j.1365-
2249.2011.04327.x 
[18] Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA (2010) 
Antibacterial effect of human mesenchymal stem cells is mediated in part from 
secretion of the antimicrobial peptide LL-37. Stem cells. 28: 2229-2238. 
[19] Lévesque JP, Winkler IG (2011) Hierarchy of immature hematopoietic cells related to 
blood flow and niche. Curr. opin. hematol. 18: 220-225. 
[20] Viljanto J (1964) Biochemical basis of tensile strength of wound healin. An experimental 
study with viscose cellulose sponges in rat. Acta chir. scand. Suppl. 333. 
[21] Matis Märtson (1999) Cellulose sponge as tissue engineering matrix: The effect of 
cellulose content, implant size and location on connective tissue and bone formation in 
rat. Annales Universitatis Turkuensis D 349. ISBN 951-29-1452-2. Doctoral thesis 
[22] Viljanto J, Jääskeläinen A (1973) Stimulation of granulation tissue growth in burns. Ann. 
chir. gyn. fenniae. 62: 18-24. 
[23] Inkinen K, Wolff H, Lindroos P, Ahonen J (2003) Connective tissue growth facor and its 
correlation to other growth factors in experimental granulation tissue. Connect. tissue 
res. 44: 19-29. 
[24] Viljanto J (1995) Cellstick device for wound healing research. In: Altmeyer P, Hoffmann 
K, el Gammal S, Hutchinson J, editors. Wound healing ad skin physiology. Springer-
Verlag. pp. 513-522.  
[25] Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. 
Semin. immunol. 20: 86-100. 
 
Cellulose - A Biomaterial with Cell-Guiding Property 101 
[26] Pulkkinen H, Tiitu V, Lammentausta E, Laasanen MS, Hämäläinen ER, Kiviranta I, 
Lammi MJ (2006) Cellulose sponge as a scaffold for cartilage tissue engineering. 
Biomed. mater. eng. 16: S29-35. 
[27] Aitasalo K, Kinnunen I, Palmgren J, Varpula M (2001) Repair of orbital floor fractures 
with bioactive glass implants. J. oral maxillofac. surg, 59: 1390-1396. 
[28] Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A (2006) Bioactive glass 
S53P4 in frontal sinus obliteration: a long-term clinica lexperience. Head neck. 28: 
834-841.  
[29] Peltola M, Suonpää J, Aitasalo K, Määttänen H, Andersson Ö, Yli-Urpo A, Laippala P 
(2000) Experimental follow-up model for clinical frontal sinus obliteration with 
bioactive glass (S53P4). Acta otolaryngol. suppl. 543: 167-169.  
[30] Stoor P, Pulkkinen J, Grénman R (2010) Bioactive glass S53P4 in the filling of cavities in 
the mastoid cell area in surgery for chronic otitis media. Ann. otol. rhinol. laryngol. 119: 
377-382. 
[31] Lindfors NC, Hyvonen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, Salo J. 
(2010) Bioactive glass S53P4 as bone graftsubstitute in treatment of osteomyelitis. Bone. 
47: 212-218.  
[32] Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ. (2010) A prospective randomized 
14-yearfollow-up study of bioactive glass andautogenous bone as bone graft substitutes 
in benign bone tumors. J. biomed. mater. res. B appl. biomater. 94: 157-164. 
[33] Kokubo T, Hata K, Nakamura T, Yamamuro T (1991) Apatite formation on ceramics, 
metals and polymers induced by CaO SiO2 based glass in a simulated body fluid. 
Bioceramics. 4: 113-120. 
[34] Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes 
MS (2002) Expression of the osteoblast differentiation factor RUNX2 
(Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J. biol. chem. 
277: 2695-2701. 
[35] Nanes MS (2003) Tumor necrosis factor : molecular and cellular mechanisms in 
skeletal pathology. Genes. 231: 1-15. 
[36] Glen Österås (2002) Utveckling av metod för framställning av cellulosapärlor. 
(Development of the method to make cellulose pearls). Åbo Academy University, 
Finland. MSc thesis. 
[37] Kalakovich KW, Boynton RE, Murphy JM, Barry F (2002) Chondrogenic differentiation 
of human mesenchymal cells within alginate culture system. In vitro cell dev. biol. 
anim. 38: 457-466. 
[38] Tommila M, Jokinen J, Wilson T, Forsback AP, Saukko P, Penttinen R, Ekholm E (2008) 
Bioactive glass-derived hydroxyapatite-coating promotes granulation tissue growth in 
subcutaneous cellulose implants in rats. Acta biomater. 4: 354-361.  
[39] Jo DY, Rafii S, Hamada T, Moore MA (2000) Chemotaxis of primitive hematopoietic 
cells in response to stromal cell-derived factor-1. J. clin. invest. 105: 101-111. 
 
Cellulose – Medical, Pharmaceutical and Electronic Applications 102 
[40] Dar A, Kollet O, Lapidot T (2006) Mutual, reciprocal SDF-1/CXCR4 interactions 
between hematopoietic and bone marrow stromal cells regulate human stem 
cell migration and development in NOD/SCID chimeric mice. Exp. hematol. 34: 967-
975. 
[41] Kaplan RN, Psaila B, Lyden D (2007) Niche-to-niche migration of bone-marrow-derived 
cells. Trends mol. med. 13: 72-81.  
[42] Schantz JT, Chim H, Whiteman M (2007) Cell guidance in tissue engineering: SDF-1 
mediates site-directed homing of mesenchymal stem cells within three-dimensional 
polycaprolactone scaffolds. Tissue eng.13: 2615-2624. 
[43] Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H (2008) Mesenchymal stem 
cells are recruited into wounded skin and contribute to wound repair by 
transdifferentiation into multiple skin cell type. J. immunol. 180: 2581-2587. 
[44] Ding J, Hori K, Zhang R, Marcoux Y, Honardoust D, Shankowsky HA, Tredget EE 
(2011) Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of 
postburn hypertrophic scar (HTS). Wound repair regen. 19: 568-578. doi: 10.1111/j.1524-
475X.2011.00724.x. 
[45] Tommila M, Jokilammi A, Terho P, Wilson T, Penttinen R, Ekholm E (2009). 
Hydroxyapatite coating of cellulose sponges attract bone-marrrow-derived stem cells in 
rat subcutaneous tissue. J. r. soc. interface. 6: 873-880.  
[46] Lancrin C, Sroczynska P, Serrano AG, Gandillet A, Ferreras C, Kouskoff V, Lacaud G 
(2010). Blood cell generation from hemangioblast. J mol. med. 88: 167-172. 
[47] Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos 
CH, Pollak MR, Brown EM, Scadden DT (2006). Stem cell engraftment at the endosteal 
niche is specified by the calcium-sensing receptor. Nature. 439: 599-603. 
[48] Wu Y, Wang J, Scott PG, Tredget EE (2007) Bone marrow-derived stem cells in wound 
healing: a review. Wound repair regen. 15: S18-26. 
[49] Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, 
Yarmush ML (2010) Mesenchymal stem cells: Mechanisms of immunomodulation and 
homing. Cell transplant. 19: 667-679. 
[50] Wannemuehler TJ, Manukyan MC, Brewster BD, Rouch J, Poynter JA, Wang Y, 
Meldrum DR (2012). Advances in mesenchymal stem cell research in sepsis. J. surg. res. 
17: 113-126.  
[51] Lazar-Karsten P, Dorn I, Meyer G, Lindner U, Driller B, Schlenke P (2011) The influence 
of extracellular matrix proteins and mesenchymal stem cells on erythropoietic cell 
maturation. Vox sang. 101: 65-76. doi: 10.1111/j.1423-0410.2010.01453.x 
[52] Tommila M, Stark C, Jokilammi A, Peltonen V, Penttinen R, Ekholm E (2011) 
Hemoglobin expression in rat experimental granulation tissue. J. mol. cell biol. 3:190-
196.  
[53] Palis P (2009) Molecular biology of erythropoiesis. In: Wickrema A, Kee B, editors. 
Molecular basis of hematopoieis, New York: Springer. pp. 73-93. 
 
Cellulose - A Biomaterial with Cell-Guiding Property 103 
[54] Chasis JA, Mohandas N (2008) Erythroblastic islands: nisches for erythropoiesis. Blood. 
112: 470-478. 
[55] Sadlon TJ, Dell’Oso T, Surinya KH, May BK (1999) Regulation of erythroid 5-
aminolevulinate synthase expression during erythropoiesis. Int. j. biochem. cell biol. 31: 
1153-1167. 
[56] Newton DA, Rao, KM, Dluhy RA, Baatz (2006) Hemoglobin is expressed by alveolar 
epithelial cell. J. biol. chem. 281: 5668-5676. 
[57] Grek CL, Newton DA, Spyropoulus DD, Baatz JE (2011 Hypoxia upregulates expression 
of haemoglobin in alveolar epithelial cells. Am. j. respir. mol. biol. 44: 439-447.  
[58] Nishi H, Inagi R, Kato H, Tanemoto M, Kojima I, Son D, Fujita T, Nangaku M (2008) 
Hemoglobin is expressed by mesangial cells and reduces oxidant stress. J. am. soc. 
nephrol. 2008 19: 1500-1508. 
[59] Dassen H, Kamps R, Punyadeera C, Dijcks F, de Goeij A, Ederveen A, Dunselman G, 
Groothuis P (2008). Haemoglobin expression in human endometrium. Hum. reprod. 23: 
635-641. 
[60] Wride MA, Mansergh FC, Adams S, Everitt R, Minnema SE, Rancourt DE, Evans  
MJ (2003) Expression profiling and gene discovery in the mouse lens. Mol. vis. 9: 360-
396. 
[61] Biagioli M, Pinto M, Cesselli D, Zaninello M, Lazarevis D, Roncalgia P, Simone R, 
Vlachouli C, Plessy C, Bertin N, Beltrami A, Kobayashi K, Gallo V, Santoro C, Ferrer I, 
Rivella S, Beltrami CA, Carninci P, Raviola E, Gustincich S (2009) Unexcpected 
expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial 
cells. Proc. natl. acad. sci. USA. 106: 15454-15459. 
[62] Schelshorn DW, Schneider A, Kuscinsky W, Weber D, Kruger C, Dittigen T, Burgers 
HF, Sabouri F, Gassler N, Bach A, Mauer MH (2009) Expression of haemoglobin in 
rodents neurons. J. cereb. blood flow metab. 29: 585-595. 
[63] Richter F, Meurers BH, Zhu C, Medvedeva VP, Chesslet MF (2009) Neurons express 
haemoglobin alpha- and beta-chains in rat and humans brains. J. comp. neurol. 515: 538-
547. 
[64] Setton-Avruj CP, Musolino PL, Salis S, Allo M, Bizzozero O, Villar MJ, Soto EF, 
Pasquini JM (2007) Prescence of alpha-globin mRNA and migration of bone marrow 
cells after sciatic nerve injury suggest their participation in the 
degeneration/regeneration process. Exp. neurol. 203: 568-578. 
[65] Liu L, Zeng M, Stamler JS (1999) Hemoglobin induction in mouse macrophages. Proc 
natl. acad. sci. USA 96: 6643-6647. 
[66] Weller R (2003) Nitric oxide: a key mediator in cutaneous physiology. Clin. exp. 
dermatol. 28: 511-514. 
[67] Schwentker A, Vodovotz Y, Weller R, Billiar TR (2002) Nitric oxide and wound repair: 
role of cytokines? Nitric oxide. 7: 1-10. 
[68] Soneja A,Drews M, Malinski T (2005). Role of nitric oxide, nitroxidative and oxidative 
stress in wound healing. Pharmacol. rep. 57 S108-109. 
 
Cellulose – Medical, Pharmaceutical and Electronic Applications 104 
[69] Luo J, Chen A (2005) Nitric oxide: a newly discovered function on wound healing. Acta 
pharmacol. sin. 26: 259-264. 
[70] Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and 
regeneration. Nature. 453: 314-321. 
